SANTECH 1A

Convertible loan
Software to quickly and cheaply deploy e-health solutions
€99,750
total amount raised
  • Backed by over 90 investors
This campaign ended

Historical accounts


The financial statements presented below are the historical accounts of Santech on 31th December 2014 and on 30th September 2015 (unaudited preliminary figures). The numbers shown below are expressed in euros.


According to our model editor, the fixed asset is fixed production that reflects a future economic benefit since it is the accounting of a part of the salary costs of R&D engineers.

The proportion of research and development in the total production of the company reflects the desire to keep a leading technology to optimize our design process and the implementation of our solution.

From an accounting point of view, the fixed asset is amortized over a period of 5 years as from the availability of the first user licenses (October 2015).



The income statement includes a research tax credit for innovative French companies which covers 30% of research and development expenditures.

For companies with Young Innovative Company Status (YIC) as Santech, this tax credit is paid back to the company and therefore can be considered as active cash assets for the company.

Financial plan


The financial plan is based on the hypothesis of obtaining French public procurement tenders which are mainly financed with Santech’s equity since public agencies generally pay upon delivery of the solution.

The assumption of a capital increase of € 2.5 million (vein), will enable the company to support its strong development and finance its growth including the strong need for working capital related to these tenders.

In addition, this capitalization comes from the perspective of increasing the solvency of the company and cover previous operating losses and short-term debts due to the lack of working capital.

Revenue drivers


Santech has two main sources of income : one linked to the direct configuration of the solutions sold to our customers and a second one related to the solutions’ software licenses.

The setting allows us to change the deployed solutions and to meet the customers’ needs.

Therefore, our solutions’ licenses continue to be active and enable growth of the users’ volume.



In the short term and with the use of Santech framework, Santech will allow third parties to rely on its technology to broadcast a maximum of E-health solutions to further increase the number of users and therefore the number of licenses sold.



The proportion of sales related to licenses should exceed the one related to the parameterization in 2017. It is at that moment that the model can play its full role and becomes truly virtuous.

Cost drivers


The main costs borne by the company are its payroll and its external costs relating to the subcontracting technical assistance to cope with peaks in terms of production needs.

Financial tables



Cash flow statement